Experimental Pharmaceutical Production Process Reduces Raw Material and Water Consumption by 50%

Implement a novel antibody purification process that utilizes precipitation and dewatering. The process controls and predictive models for the new process will be implemented on the CESMII Smart Manufacturing Innovation Platform (SMIP).

Improving pharmaceutical manufacturing operational efficiency leads to increased production capacities and reduced operating costs, enabling pharmaceutical companies to make medications more affordable and accessible to patients across the nation. Advancing pharmaceutical manufacturing processes not only supports American public health, but also strengthens the nation's position as a world leader in pharmaceutical manufacturing.

Reducing raw material and water consumption in pharmaceutical manufacturing reduces the sector’s carbon footprint and enhances its reputation with consumers. Implementing eco-friendly production practices aligns with the growing global demand for environmentally responsible products, giving pharmaceutical companies a competitive edge. Improving cost-efficiency also yields higher profit margins and enables pharmaceutical companies to reinvest in research and development, contributing to the long-term growth of the industry.